NCT01523197

Brief Summary

Obstructive Sleep Apnea Syndrome (OSAS) and chronic obstructive pulmonary disease (COPD) are two diseases that often coexist and are called overlap syndrome(OS). Compared to single OSAS, OS patients are more susceptible to serious hypoxia and hypercapnia especially during sleep, and are much more likely to result in pulmonary hypertension and cor-pulmonal. With a more flexible expiratory positive airway pressure (EPAP), auto-trilevel ventilation may be superior to fixed bilevel positive airway pressure (BiPAP) ventilation in both removing residual obstructive sleep apnea hypopnea events and correcting hypercapnia simultaneously. The overall purpose of this study is to compare the curative effects between fixed BiPAP and auto-trilevel ventilations on OS patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2011

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

January 12, 2012

Completed
20 days until next milestone

First Posted

Study publicly available on registry

February 1, 2012

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2012

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2012

Completed
Last Updated

November 27, 2012

Status Verified

November 1, 2012

Enrollment Period

1.2 years

First QC Date

January 12, 2012

Last Update Submit

November 26, 2012

Conditions

Keywords

Obstructive Sleep Apnea hypopnea SyndromeCOPDoverlap syndromeAuto-trilevel ventilationBiPAP ventilation

Outcome Measures

Primary Outcomes (1)

  • different effects between BiPAP and auto-Trilevel ventilators on OS

    The overall purpose of this study is to determine the effects of auto-Trilevel ventilation on patients with overlap syndrome by comparison with BiPAP ventilation. The following parameters are compared such as apnea hypopnea index, lowest SPO2, arousal index, sleep efficiency, PaCO2, daytime sleepiness and so on.

    Participants will be observed for the duration of hospital stay, an expected average of 1 weeks

Study Arms (1)

ventilator

OTHER

The comparison of the curative effect on OS between BiPAP and auto-trilevel ventilations

Device: BiPAP ventilation, auto-trilevel ventilation

Interventions

Noninvasive ventilation including fixed BiPAP ventilation and auto-trilevel ventilation. Using the same IPAP, treatment include one night with BiPAP ventilation mode 1, one night with BiPAP ventilation mode 2 and one night with auto-trilevel ventilation mode. Each treatment last 8 hours for each night.

Also known as: bi-level postive airway preesure ventilation;, auto-trilevel ventilation
ventilator

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient or legal representative of the patient is willing and able to sign an approved informed consent and privacy protection authorization in the United States.
  • Subject is \>18 years old.
  • Diagnosed overlap syndrome(OSAS and COPD). 4. Expected to tolerate the ventilator therapy .

You may not qualify if:

  • Patient is currently enrolled in another clinical study which may confound the result of this study.
  • Patient for who inform consent cannot be obtained.
  • Patients with a history of cerebrovascular accident within the 6 months prior to this study.
  • Patients with acute or chronic renal failure, diabetes and severe lung diseases.
  • Patients with unstable angina.
  • Patient who is of pregnant or during lactation period.
  • Patients with a history of injury or surgery within 6 months prior to the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Nanjing Medical University

Nanjing, Jiangsu, China

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • xilong zhang, MD

    The First Affiliated Hospital with Nanjing Medical University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Department of Respirology, The First Affiliated Hospital of Nanjing Medical University

Study Record Dates

First Submitted

January 12, 2012

First Posted

February 1, 2012

Study Start

August 1, 2011

Primary Completion

October 1, 2012

Study Completion

November 1, 2012

Last Updated

November 27, 2012

Record last verified: 2012-11

Locations